Oracle has released version 26 of the Java programming language and virtual machine. As the first non-LTS release since JDK ...

Oracle uses JavaOne 2026 to launch JDK 26 and argue that Java can stay relevant in the AI era by building on its traditional strengths in performance, language evolution, and enterprise stability.

Overview:  The right Java books build strong fundamentals and improve coding confidence.Combine Core Java basics with ...

Telefónica and Mavenir Bet on AI-Run Networks With New Innovation Hub Your email has been sent Telefónica and Mavenir are setting up a joint AI Innovation Hub to test and validate AI-driven ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Starting in autumn quarter 2025, the University will begin a multi-year restructuring of the undergraduate writing program, which had previously run concurrently with the humanities Core sequence.

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.